Usability of Virtual Reality in Subjects With Mild Cognitive Impairment or Alzheimer's Disease
NCT ID: NCT02176629
Last Updated: 2015-09-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2014-08-31
2015-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In terms of prevention as term care , there is now a broad consensus that interventions on cognition and behavior must not be limited to pharmacological treatment but should also promote non-drug approaches.
Interest in video games (serious games and serious games) as intervention support rehabilitation is growing. Similarly, the virtual reality (VR) and the new information technologies and communications offer significant opportunities in terms of rehabilitation and therapeutic assistance.
This protocol is part of a European project to propose techniques for improving the treatment of people at risk of social exclusion ( VERVE project ) aims .
A first experiment conducted in 2013 showed the acceptability of Virtual Reality (VR) in healthy elderly subjects. In a second step , it is important to validate the feasibility of using the RV or in frail subjects with mild cognitive impairment or Alzheimer's disease in mild to moderate in a clinical environment.
This is a biomedical , randomized given to a group of patients with mild cognitive impairment or Alzheimer's disease \& diseases associated with mild to moderate.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cognitive Remediation VR Tool for People With MCI: a Feasibility RCT
NCT06270966
Tolerance of an Immersive Virtual Reality Task Evaluating the Spatial Memory of Elderly Subjects
NCT05996250
REMINISCENCES and EMOTIONS : Reminiscence Triggered by Virtual Reality for Older Adults With Mood Disorders
NCT04442594
New Virtual Reality Technologies and Telemedicine for Cognitive Rehabilitation in Alzheimer's Disease
NCT05697354
Network Modulation in Alzheimer's Disease
NCT04045990
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Condition virtual reality (VR)
The subject is placed in front of a Barcotm screen capable of displaying high quality images.
Condition virtual reality (VR) then Condition classic cognitive stimulation (CCS)
Condition classic cognitive stimulation (CSC)
It is proposed about using the test dam Zazzo suitable for elderly. This classic test measures sustained attention.
Condition classic cognitive stimulation (CCS) then Condition virtual reality (VR)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Condition virtual reality (VR) then Condition classic cognitive stimulation (CCS)
Condition classic cognitive stimulation (CCS) then Condition virtual reality (VR)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Introducing either:
* MCI diagnosis (ICD-10)
* diagnosis of Alzheimer's disease or mixed mild to moderate (ICD 10).
* Subject undisturbed locomotion requiring the use of a walking aid.
* Score at the Mini Mental Test (MMSE) between 16 and 28.
Exclusion Criteria
* Presence of eye diseases causing blurred vision can not be corrected with lenses or glasses.
* Presence of auditory pathologies causing a significant decrease in hearing unaided.
* High sensitivity to motion sickness.
* migraine disease.
* Subject epileptic.
* Subject vulnerable
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de Nice
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Philippe ROBERT, PUPH
Role: STUDY_DIRECTOR
Centre Hospitalier Universitaire de Nice
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institut Claude Pompidou
Nice, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
14-PP-03
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.